论文信息 - Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial - 字舞流文

Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial

S. Hober | H. Ljunggren | P. Ljungman | Piotr Nowak | G. Bogdanovic | A. Österborg | K. Loré | M. Buggert | G. Söderdahl | D. Valentini | P. Bergman | Gustaf Lindgren | S. Muschiol | M. Akber | S. Aleman | M. Chen | J. Vesterbacka | C. E. Edvard Smith | G. Friman | L. Hansson | A. Thalme | Anna-Carin Norlin | O. Blennow | Puran Chen | A. Nordlander | P. Nilsson | G. Lindgren | Angela C. Gomez | Stephanie Mielke | David Wullimann | Lisa Blixt | Emilie Wahren-Borgström | Mira Akber | A. Norlin | D. Wullimann